Mapping Patterns of Ipsilateral Supraclavicular Nodal Metastases in Breast Cancer: Rethinking the Clinical Target Volume for High-risk Patients

医学 地图集(解剖学) 乳腺癌 放射治疗 淋巴结 放射科 锁骨 癌症 内科学 外科 解剖
作者
Jing Hao,Shulian Wang,Jing Li,Mei Xue,Xiong Zukun,Jing Jin,Weihu Wang,Yong-Wen Song,Yueping Liu,Hua Ren,Hui Fang,Zi-Hao Yu,Xin-Fan Liu,Yexiong Li
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
卷期号:93 (2): 268-276 被引量:51
标识
DOI:10.1016/j.ijrobp.2015.08.022
摘要

To map the location of metastatic supraclavicular (SCV) lymph nodes (LNMs) in breast cancer patients with SCV node involvement and determine whether and where the radiation therapy clinical target volume (CTV) of this region could be modified in high-risk subsets.Fifty-five patients with metastatic SCV LNMs were eligible for geographic mapping and atlas coverage analysis. All LNMs and their epicenters were registered proportionally by referencing the surrounding landmarks onto simulation computed tomography images of a standard patient. CTVs based on selected SCV atlases, including the one by the Radiation Therapy Oncology Group (RTOG) were contoured. A modified SCV CTV was tried and shown to have better involved-node coverage and thus theoretically improved prophylaxis in this setting.A total of 50 (91%) and 45 (81.8%) patients had LNMs in the medial and lateral SCV subregions, respectively. Also, 36 patients (65.5%) had LNMs located at the junction of the jugular-subclavian veins. All nodes were covered in only 25.5% to 41.8% of patients by different atlases. The RTOG atlas covered all nodes in 25.5% of patients. Stratified by the nodes in all the patients as a whole, 49.2% to 81.3% were covered, and the RTOG atlas covered 62.6%. The lateral and posterior borders were the most overlooked locations. Modification by extending the borders to natural anatomic barriers allowed the new CTV to cover all the nodes in 81.8% of patients and encompass 96.1% of all the nodes.According to the distribution of SCV LNMs, the extent of existing atlases might not be adequate for potential metastatic sites in certain groups of patients. The extension of the lateral and posterior CTV borders in high-risk or recurrent patients might be a reasonable approach for increasing coverage. However, additional data in more homogeneous populations with localized disease are needed before routine application.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
夜乡晨发布了新的文献求助10
刚刚
wanci应助wcli采纳,获得10
刚刚
乐乐应助66采纳,获得10
1秒前
芒果发布了新的文献求助10
1秒前
研友_VZG7GZ应助yaoyao采纳,获得10
1秒前
大模型应助ohh采纳,获得10
2秒前
zhan发布了新的文献求助10
2秒前
3秒前
Dr.Tang完成签到 ,获得积分10
3秒前
无花果应助科研小白采纳,获得10
4秒前
yang发布了新的文献求助10
4秒前
客服完成签到 ,获得积分10
4秒前
无花果应助秦际凡采纳,获得10
5秒前
深情安青应助lza采纳,获得10
5秒前
科研通AI6.2应助无心将城采纳,获得10
6秒前
麦子应助柯南爱上了美芽采纳,获得10
7秒前
7秒前
7秒前
7秒前
GAN完成签到,获得积分10
8秒前
8秒前
专注的思菱完成签到,获得积分10
8秒前
杨依楠完成签到,获得积分10
8秒前
yyj完成签到,获得积分10
9秒前
zhang完成签到,获得积分10
9秒前
Whim应助昏睡的以南采纳,获得20
10秒前
柒姐应助海边烤苞米采纳,获得10
10秒前
Ge完成签到,获得积分10
12秒前
杨羊羊发布了新的文献求助10
12秒前
childe完成签到,获得积分10
14秒前
草本完成签到,获得积分10
14秒前
姜小麦完成签到,获得积分10
14秒前
Lucas应助weiwei采纳,获得10
14秒前
15秒前
玩命的世开完成签到,获得积分10
15秒前
KDVBHGJDFHGAV应助hsa_ID采纳,获得10
15秒前
干净的琦应助给个修远兮采纳,获得10
15秒前
16秒前
优美的芷天完成签到 ,获得积分10
16秒前
chen完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Burger's Medicinal Chemistry, Drug Discovery and Development, Volumes 1 - 8, 8 Volume Set, 8th Edition 1800
Cronologia da história de Macau 1600
Netter collection Volume 9 Part I upper digestive tract及Part III Liver Biliary Pancreas 3rd 2024 的超高清PDF,大小约几百兆,不是几十兆版本的 1050
Current concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents 1000
Research Handbook on the Law of the Sea 1000
Contemporary Debates in Epistemology (3rd Edition) 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6168730
求助须知:如何正确求助?哪些是违规求助? 7996426
关于积分的说明 16630766
捐赠科研通 5273979
什么是DOI,文献DOI怎么找? 2813579
邀请新用户注册赠送积分活动 1793314
关于科研通互助平台的介绍 1659250